State Street SPDR S&P Pharmaceuticals ETF (XPH)
State Street / SPDR
- Page updated:
- Sep 8, 2026
- Data as of:
- Sep 3, 2026
Fund identity
- Ticker
- XPH
- Fund name
- State Street SPDR S&P Pharmaceuticals ETF
- Fund type
- ETF
- Listing venue
- NYSE Arca
- Currency
- USD
- Domicile
- US
- Inception
- Jun 19, 2006
Structure and strategy
- Sponsor
- State Street / SPDR
- Management approach
- Passive
- Strategy
- Tracks the S&P Pharmaceuticals Select Industry Index.
- Portfolio scope
- U.S.-listed pharmaceuticals equities
- Portfolio implementation
- Modified-equal-weight/select-industry index tracking
- Benchmark
- S&P Pharmaceuticals Select Industry Index
- Asset class
- Equity
- Category
- Pharmaceuticals
Costs and minimums
- Gross expense ratio
- 0.35%
- Gross expense ratio
- 0.35%
- Ongoing fee as of
- Sep 7, 2026
Size and distributions
- Assets under management
- $620.88M
- Assets under management scope
- Fund
- Reported holdings count
- 64
- Distribution frequency
- Quarterly
Sources
- XPH issuer disclosure — State Street / SPDR · data as of Sep 7, 2026
Learn the basics
ROIStreet publishes this reference data for education and research. Figures are as of the dates shown, are not real-time quotes, and are not investment advice. Verify details with the issuer or provider before acting.